Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
ImmunoHorizons · 01.03.2024 · 8 (3) · 214-226
DOI: 10.4049/immunohorizons.2400003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ImmunoHorizons, online erschienen am 01.03.2024. Verfasst von Nicholas Magazine und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Despite the success of global vaccination programs in slowing the spread of COVID-19, these efforts have been hindered by the emergence of new SARS-CoV-2 strains capable of evading prior immunity. The mutation and evolution of SARS-CoV-2 have created a demand for persistent efforts in vaccine development. SARS-CoV-2 Spike protein has been the primary target for COVID-19 vaccine development, but it is also the hotspot of mutations directly involved in host susceptibility and virus immune evasion. Our ability to predict emerging mutants and select conserved epitopes is critical for the development of a broadly neutralizing therapy or a universal vaccine. In this article, we review the general paradigm of immune responses to COVID-19 vaccines, highlighting the immunological epitopes of Spike protein that are likely associated with eliciting protective immunity resulting from vaccination in humans. Specifically, we analyze the structural and evolutionary characteristics of the SARS-CoV-2 Spike protein related to immune activation and function via the TLRs, B cells, and T cells. We aim to provide a comprehensive analysis of immune epitopes of Spike protein, thereby contributing to the development of new strategies for broad neutralization or universal vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA.
- Department of Mathematics, University of Houston, Houston, TX.
- Division of Biotechnology and Molecular Medicine, Louisiana State University, Baton Rouge, LA.
- Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY.
ORCID-Profile: Anang D Bungwon, Yingying Wu, Gianluca Veggiani, Weishan Huang
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- Louisiana State University
- American Association of University Women
Zitieren
APA
Magazine, N., Zhang, T., Bungwon, A. D., McGee, M. C., Wu, Y., Veggiani, G., & Huang, W. (2024). Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development. ImmunoHorizons, 8(3), 214-226. https://doi.org/10.4049/immunohorizons.2400003
Vancouver
Magazine N, Zhang T, Bungwon AD, McGee MC, Wu Y, Veggiani G, et al. Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development. ImmunoHorizons. 2024;8(3):214-226. doi:10.4049/immunohorizons.2400003
BibTeX
@article{Magazine2024,
author = {Magazine, Nicholas and Zhang, Tianyi and Bungwon, Anang D and McGee, Michael C and Wu, Yingying and Veggiani, Gianluca and Huang, Weishan},
title = {Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development},
journal = {ImmunoHorizons},
year = {2024},
volume = {8},
number = {3},
pages = {214--226},
doi = {10.4049/immunohorizons.2400003}
}
EUVIMED